Stryker announces $250M accelerated share repurchase program Stryker Corporation announced it has entered into an Accelerated Share Repurchase agreement with JPMorgan Chase Bank, NA to repurchase an aggregate of $250M of the Company's common stock. The ASR is part of the Company's existing share repurchase authorization that was increased by the Board of Directors to $1.0B in December 2012. Under the ASR agreement, Stryker will receive approximately 3.6M shares at the inception of the ASR. The total number of shares ultimately repurchased under the agreement will be determined upon the final settlement, using prices based generally on the average of the daily volume-weighted average price of the Company's common stock over a period of time expected to end in the first half of 2013. The ASR will be funded through existing cash on hand. The ASR will reduce the Company's existing share repurchase authorization to approximately $750M at the final settlement of the agreement.
Leerink medical devices analyst holds an analyst/industry conference call Medical Device Analyst Newitter, along with MEDACorp Specialists Dorance Dillon and Terence Farrell, discuss the Centers for Medicare & Medicaid Services' recently proposed "Comprehensive Care For Joint Replacement Payment Model" and how this model might influence ortho pricing and hospital-vendor relationships on an Analyst/Industry conference call to be held on August 24 at 1 pm.